Half of advanced melanoma patients live for 10 years with double drug treatment

Experts hail ‘remarkable’ trial results for treatment of a form of skin cancer that once had grim prognosisMore than half of people diagnosed with advanced melanoma now survive for at least 10 years when they receive a double hit of immunotherapy drugs, a trial has found.The combined treatment has transformed survival rates for a form of skin cancer that once had a grim prognosis, with some patients now living long enough that they die from other causes. Continue reading...

Half of advanced melanoma patients live for 10 years with double drug treatment

Experts hail ‘remarkable’ trial results for treatment of a form of skin cancer that once had grim prognosis

More than half of people diagnosed with advanced melanoma now survive for at least 10 years when they receive a double hit of immunotherapy drugs, a trial has found.

The combined treatment has transformed survival rates for a form of skin cancer that once had a grim prognosis, with some patients now living long enough that they die from other causes. Continue reading...